US Patent Issued to POLYGON THERAPEUTICS on Jan. 13 for "Anti-CD8 alpha depleting antibodies" (French Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,659, issued on Jan. 13, was assigned to POLYGON THERAPEUTICS (Levallois-perret, France).

"Anti-CD8 alpha depleting antibodies" was invented by Tatiana Monseur (Levallois-perret, France) and Mohamed Abou Ali (Levallois-perret, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Novel anti-CD8Alpha (cluster of differentiation 8 alpha) antibodies and antigen-binding fragments thereof, a fusion protein including the anti-CD8Alpha antibodies and antigen-binding fragments thereof, and a nucleic acid molecule encoding the anti-CD8Alpha antibodies and antigen-binding fragments thereof. Also, pharmaceutical compositions including the anti-CD8Alpha antibodi...